M&A Deal Summary

Ampersand Capital Partners Acquires Tjoapack

On April 21, 2020, growth capital firm Ampersand Capital Partners acquired packaging company Tjoapack

Acquisition Highlights
  • This is Ampersand Capital Partners’ 1st transaction in the Packaging sector.
  • This is Ampersand Capital Partners’ 2nd transaction in the Netherlands.

M&A Deal Summary
Date 2020-04-21
Target Tjoapack
Sector Packaging
Buyer(s) Ampersand Capital Partners
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Marktlink Mergers & Acquisitions (Financial)

Target

Tjoapack

Etten-Leur, Netherlands
Tjoapack is a contract packager of medicines servicing clients across five continents and 42 countries. The CPO specializes in primary packaging for solid dosage forms, secondary packaging, and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets, and bottles. Tjoapack was founded in 1989 and is based in Etten-Leur, Netherlands.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 55 of 82
Sector (Packaging) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 19 of 23
Country (Netherlands) 2 of 3
Year (2020) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-13 Interpace

Parsippany, New Jersey, United States

Interpace engages in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Interpace Biosciences was founded in 1986 and is based in Parsippany, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-11 Canopy Biosciences

St. Louis, Missouri, United States

Canopy Biosciences LLC is a provider of gene editing and gene expression products and services. Canopy's gene-editing portfolio spans easy-to-use CRISPR kits, off-the-shelf cell lines, as well as full-service custom cell line engineering. Canopy Biosciences was founded in 2016 and is based in St. Louis, Missouri.

Sell -
Mergr

Product

Company

Legal